![Achievements and challenges in the use of metronomics for the treatment of breast cancer - ScienceDirect Achievements and challenges in the use of metronomics for the treatment of breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295220301374-ga1.jpg)
Achievements and challenges in the use of metronomics for the treatment of breast cancer - ScienceDirect
![Pharmaceuticals | Free Full-Text | Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics Pharmaceuticals | Free Full-Text | Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00970/article_deploy/html/images/pharmaceuticals-14-00970-g001-550.jpg)
Pharmaceuticals | Free Full-Text | Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics
![Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects | Nature Reviews Clinical Oncology Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrclinonc.2016.57/MediaObjects/41571_2016_Article_BFnrclinonc201657_Fig1_HTML.jpg)
Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects | Nature Reviews Clinical Oncology
![Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress | ACS Applied Materials & Interfaces Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress | ACS Applied Materials & Interfaces](https://pubs.acs.org/cms/10.1021/acsami.0c17326/asset/images/large/am0c17326_0012.jpeg)
Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress | ACS Applied Materials & Interfaces
![Effect of OXi4503 (OXi) and monoclonal antibody inhibitors (10 mg/kg)... | Download Scientific Diagram Effect of OXi4503 (OXi) and monoclonal antibody inhibitors (10 mg/kg)... | Download Scientific Diagram](https://www.researchgate.net/publication/342721692/figure/fig2/AS:910483590742016@1594087612719/Effect-of-OXi4503-OXi-and-monoclonal-antibody-inhibitors-10-mg-kg-of-PD-1-PD-L1-and.png)
Effect of OXi4503 (OXi) and monoclonal antibody inhibitors (10 mg/kg)... | Download Scientific Diagram
![OXIS International, Inc. (OTCQB: OXIS) Dives 30% After Enrolling Two New Patents For Its Cancer Drug, OXS-1550 - EmergingGrowth.com OXIS International, Inc. (OTCQB: OXIS) Dives 30% After Enrolling Two New Patents For Its Cancer Drug, OXS-1550 - EmergingGrowth.com](https://emerginggrowth.com/wp-content/uploads/2017/01/Cancer-Treatment-Trials.jpg)
OXIS International, Inc. (OTCQB: OXIS) Dives 30% After Enrolling Two New Patents For Its Cancer Drug, OXS-1550 - EmergingGrowth.com
![Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02141-z/MediaObjects/13046_2021_2141_Fig1_HTML.png)